INTERNATIONAL PATENT: NODTHERA LIMITED FILES APPLICATION FOR "NLRP3 INHIBITORS AND GLP-1 AGONISTS COMBINATION THERAPIES"

GENEVA, July 29 -- NODTHERA LIMITED (Suite 8, The Mansion, Chesterford Research ParkLittle Chesterford CB10 1XL) filed a patent application (PCT/EP2025/050888) for "NLRP3 INHIBITORS AND GLP-1 AGONISTS COMBINATION THERAPIES" on Jan 15, 2025. With publication no. WO/2025/153532, the details related to the patent application was published on Jul 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WATT, Alan Paul (c/o NodThera Limited, Suite 8, The Mansion,Chesterford Research ParkLittle Chesterford CB10 1XL), CLARKE, Nicholas (c/o NodThera Limited, Suite 8, The Mansion,Chesterford Research Park...